CytomX Therapeutics, Inc. (CTMX)
4.40
-0.16
(-3.51%)
USD |
NASDAQ |
Apr 06, 16:00
4.39
-0.01
(-0.23%)
After-Hours: 20:00
CytomX Therapeutics SG&A Expense (TTM) : 29.84M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Rigel Pharmaceuticals, Inc. | 115.90M |
| REGENXBIO, Inc. | 82.86M |
| Ovid Therapeutics, Inc. | 24.11M |
| Olema Pharmaceuticals, Inc. | 21.00M |